{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:21:27Z","timestamp":1761294087811},"publisher-location":"New York, NY","reference-count":31,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071604335"},{"type":"electronic","value":"9781071604342"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-1-0716-0434-2_15","type":"book-chapter","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T15:42:59Z","timestamp":1583509379000},"page":"313-326","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Investigating the Effects of O-GlcNAc Modifications in Parkinson\u2019s Disease Using Semisynthetic \u03b1-Synuclein"],"prefix":"10.1007","author":[{"given":"Ana","family":"Galesic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,7]]},"reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3406","volume":"14","author":"HA Lashuel","year":"2013","unstructured":"Lashuel HA, Overk CR, Oueslati A, Masliah E (2013) The many faces of \u03b1-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci 14:38\u201348. \nhttps:\/\/doi.org\/10.1038\/nrn3406","journal-title":"Nat Rev Neurosci"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1126\/science.1252884","volume":"344","author":"BG Wilhelm","year":"2014","unstructured":"Wilhelm BG, Mandad S, Truckenbrodt S, Kr\u00f6hnert K, Sch\u00e4fer C, Rammner B et al (2014) Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins. Science 344:1023\u20131028. \nhttps:\/\/doi.org\/10.1126\/science.1252884","journal-title":"Science"},{"key":"15_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fnmol.2016.00048","volume":"9","author":"C Wang","year":"2016","unstructured":"Wang C, Zhao C, Li D, Tian Z, Lai Y, Diao J et al (2016) Versatile structures of \u03b1-synuclein. Front Mol Neurosci 9:48. \nhttps:\/\/doi.org\/10.3389\/fnmol.2016.00048","journal-title":"Front Mol Neurosci"},{"key":"15_CR4","doi-asserted-by":"publisher","first-page":"19666","DOI":"10.1073\/pnas.0807826105","volume":"105","author":"CC Jao","year":"2008","unstructured":"Jao CC, Hegde BG, Chen J, Haworth IS, Langen R (2008) Structure of membrane-bound alpha-synuclein from site-directed spin labeling and computational refinement. Proc Natl Acad Sci USA 105:19666\u201319671. \nhttps:\/\/doi.org\/10.1073\/pnas.0807826105","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR5","doi-asserted-by":"publisher","first-page":"32486","DOI":"10.1074\/jbc.M110.139576","volume":"285","author":"J Varkey","year":"2010","unstructured":"Varkey J, Isas JM, Mizuno N, Jensen MB, Bhatia VK, Jao CC et al (2010) Membrane curvature induction and tubulation are common features of synucleins and apolipoproteins. J Biol Chem 285:32486\u201332493. \nhttps:\/\/doi.org\/10.1074\/jbc.M110.139576","journal-title":"J Biol Chem"},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"29301","DOI":"10.1074\/jbc.M112.365817","volume":"287","author":"N Mizuno","year":"2012","unstructured":"Mizuno N, Varkey J, Kegulian NC, Hegde BG, Cheng N, Langen R et al (2012) Remodeling of lipid vesicles into cylindrical micelles by \u03b1-synuclein in an extended \u03b1-helical conformation. J Biol Chem 287:29301\u201329311. \nhttps:\/\/doi.org\/10.1074\/jbc.M112.365817","journal-title":"J Biol Chem"},{"key":"15_CR7","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3390\/biom5020865","volume":"5","author":"M Emanuele","year":"2015","unstructured":"Emanuele M, Chieregatti E (2015) Mechanisms of alpha-synuclein action on neurotransmission: cell-autonomous and non-cell autonomous role. Biomolecules. 5:865\u2013892. \nhttps:\/\/doi.org\/10.3390\/biom5020865","journal-title":"Biomolecules."},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1021\/ar050073t","volume":"39","author":"AL Fink","year":"2006","unstructured":"Fink AL (2006) The aggregation and fibrillation of \u03b1-synuclein. Acc Chem Res 39:628\u2013634. \nhttps:\/\/doi.org\/10.1021\/ar050073t","journal-title":"Acc Chem Res"},{"key":"15_CR9","doi-asserted-by":"publisher","first-page":"19509","DOI":"10.1074\/jbc.274.28.19509","volume":"274","author":"SJ Wood","year":"1999","unstructured":"Wood SJ, Wypych J, Steavenson S, Louis JC, Citron M, Biere AL (1999) alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson\u2019s disease. J Biol Chem 274:19509\u201319512. \nhttps:\/\/doi.org\/10.1074\/jbc.274.28.19509","journal-title":"J Biol Chem"},{"key":"15_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0079-6123(10)83007-9","volume":"183","author":"A Oueslati","year":"2010","unstructured":"Oueslati A, Fournier M, Lashuel HA (2010) Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies. Prog Brain Res. 183:115\u2013145. \nhttps:\/\/doi.org\/10.1016\/S0079-6123(10)83007-9","journal-title":"Prog Brain Res."},{"key":"15_CR11","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1074\/mcp.R113.032730","volume":"12","author":"AW Schmid","year":"2013","unstructured":"Schmid AW, Fauvet B, Moniatte M, Lashuel HA (2013) Alpha-synuclein post-translational modifications as potential biomarkers for Parkinson disease and other synucleinopathies. Mol Cell Proteomics 12:3543\u20133558. \nhttps:\/\/doi.org\/10.1074\/mcp.R113.032730","journal-title":"Mol Cell Proteomics"},{"key":"15_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2337\/db08-0994","volume":"58","author":"Z Wang","year":"2009","unstructured":"Wang Z, Park K, Comer F, Hsieh-Wilson LC, Saudek CD, Hart GW (2009) Site-specific GlcNAcylation of human erythrocyte proteins potential biomarker(s) for diabetes. Diabetes 58:309\u2013317. \nhttps:\/\/doi.org\/10.2337\/db08-0994","journal-title":"Diabetes"},{"key":"15_CR13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1074\/mcp.M900268-MCP200","volume":"9","author":"Z Wang","year":"2010","unstructured":"Wang Z, Udeshi ND, O'Malley M, Shabanowitz J, Hunt DF, Hart GW (2010) Enrichment and site mapping of O-linked N-acetylglucosamine by a combination of chemical\/enzymatic tagging, photochemical cleavage, and electron transfer dissociation mass spectrometry. Mol Cell Proteomics 9:153\u2013160. \nhttps:\/\/doi.org\/10.1074\/mcp.M900268-MCP200","journal-title":"Mol Cell Proteomics"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"7280","DOI":"10.1073\/pnas.1200425109","volume":"109","author":"JF Alfaro","year":"2012","unstructured":"Alfaro JF, Gong C-X, Monroe ME, Aldrich JT, Clauss TRW, Purvine SO et al (2012) Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets. Proc Natl Acad Sci USA 109:7280\u20137285. \nhttps:\/\/doi.org\/10.1073\/pnas.1200425109","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR15","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/nn.4067","volume":"18","author":"M Morris","year":"2015","unstructured":"Morris M, Knudsen GM, Maeda S, Trinidad JC, Ioanoviciu A, Burlingame AL et al (2015) Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice. Nat Neurosci. 18:1183\u20131189. \nhttps:\/\/doi.org\/10.1038\/nn.4067","journal-title":"Nat Neurosci."},{"key":"15_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/path.4929","volume":"243","author":"S Wang","year":"2017","unstructured":"Wang S, Yang F, Petyuk VA, Shukla AK, Monroe ME, Gritsenko MA et al (2017) Quantitative proteomics identifies altered O-GlcNAcylation of structural, synaptic and memory-associated proteins in Alzheimer\u2019s disease. J Pathol 243:78\u201388. \nhttps:\/\/doi.org\/10.1002\/path.4929","journal-title":"J Pathol"},{"key":"15_CR17","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1083\/jcb.201501101","volume":"208","author":"MR Bond","year":"2015","unstructured":"Bond MR, Hanover JA (2015) A little sugar goes a long way: the cell biology of O-GlcNAc. J Cell Biol 208:869\u2013880. \nhttps:\/\/doi.org\/10.1083\/jcb.201501101","journal-title":"J Cell Biol"},{"key":"15_CR18","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nrm.2017.22","volume":"18","author":"X Yang","year":"2017","unstructured":"Yang X, Qian K (2017) Protein O-GlcNAcylation: emerging mechanisms and functions. Nat Rev Mol Cell Biol 18:452\u2013465. \nhttps:\/\/doi.org\/10.1038\/nrm.2017.22","journal-title":"Nat Rev Mol Cell Biol"},{"key":"15_CR19","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1128\/MCB.24.4.1680-1690.2004","volume":"24","author":"N O\u2019Donnell","year":"2004","unstructured":"O\u2019Donnell N, Zachara NE, Hart GW, Marth JD (2004) Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability. Mol Cell Biol 24:1680\u20131690","journal-title":"Mol Cell Biol"},{"key":"15_CR20","doi-asserted-by":"publisher","first-page":"15120","DOI":"10.1073\/pnas.1606899113","volume":"113","author":"AC Wang","year":"2016","unstructured":"Wang AC, Jensen EH, Rexach JE, Vinters HV, Hsieh-Wilson LC (2016) Loss of O-GlcNAc glycosylation in forebrain excitatory neurons induces neurodegeneration. Proc Natl Acad Sci USA 113:15120\u201315125. \nhttps:\/\/doi.org\/10.1073\/pnas.1606899113","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR21","doi-asserted-by":"publisher","first-page":"10804","DOI":"10.1073\/pnas.0400348101","volume":"101","author":"F Liu","year":"2004","unstructured":"Liu F, Iqbal K, Grundke-Iqbal I, Hart G, Gong C (2004) O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer\u2019s disease. Proc Natl Acad Sci USA 101:10804\u201310809","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR22","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1002\/cbic.201700515","volume":"18","author":"AL Aguilar","year":"2017","unstructured":"Aguilar AL, Hou X, Wen L, Wang PG, Wu P (2017) A chemoenzymatic histology method for O-GlcNAc detection. ChemBioChem 18:2416\u20132421. \nhttps:\/\/doi.org\/10.1002\/cbic.201700515","journal-title":"ChemBioChem"},{"key":"15_CR23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nchembio.797","volume":"8","author":"SA Yuzwa","year":"2012","unstructured":"Yuzwa SA, Shan X, Macauley MS, Clark T, Skorobogatko Y, Vosseller K et al (2012) Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation. Nat Chem Biol 8:393\u2013399. \nhttps:\/\/doi.org\/10.1038\/nchembio.797","journal-title":"Nat Chem Biol"},{"key":"15_CR24","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/j.jmb.2014.01.004","volume":"426","author":"SA Yuzwa","year":"2014","unstructured":"Yuzwa SA, Cheung AH, Okon M, McIntosh LP, Vocadlo DJ (2014) O-GlcNAc modification of tau directly inhibits its aggregation without perturbing the conformational properties of tau monomers. J Mol Biol. 426:1736\u20131752. \nhttps:\/\/doi.org\/10.1016\/j.jmb.2014.01.004","journal-title":"J Mol Biol."},{"key":"15_CR25","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/nchem.2361","volume":"7","author":"NP Marotta","year":"2015","unstructured":"Marotta NP, Lin YH, Lewis YE, Ambroso MR, Zaro BW, Roth MT et al (2015) O-GlcNAc modification blocks the aggregation and toxicity of the protein \u03b1-synuclein associated with Parkinson's disease. Nat Chem. 7:913\u2013920. \nhttps:\/\/doi.org\/10.1038\/nchem.2361","journal-title":"Nat Chem."},{"key":"15_CR26","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1021\/acschembio.7b00113","volume":"12","author":"YE Lewis","year":"2017","unstructured":"Lewis YE, Galesic A, Levine PM, De Leon CA, Lamiri N, Brennan CK et al (2017) O-GlcNAcylation of \u03b1-synuclein at serine 87 reduces aggregation without affecting membrane binding. ACS Chem Biol 12:1020\u20131027. \nhttps:\/\/doi.org\/10.1021\/acschembio.7b00113","journal-title":"ACS Chem Biol"},{"key":"15_CR27","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1073\/pnas.1808845116","volume":"116","author":"PM Levine","year":"2019","unstructured":"Levine PM, Galesic A, Balana AT, Mahul-Mellier A-L, Navarro MX, De Leon CA et al (2019) \u03b1-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson\u2019s disease. Proc Natl Acad Sci USA 116:1511\u20131519. \nhttps:\/\/doi.org\/10.1073\/pnas.1808845116","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.neulet.2017.06.034","volume":"655","author":"J Zhang","year":"2017","unstructured":"Zhang J, Lei H, Chen Y, Ma Y-T, Jiang F, Tan J et al (2017) Enzymatic O-GlcNAcylation of \u03b1-synuclein reduces aggregation and increases SDS-resistant soluble oligomers. Neurosci Lett 655:90\u201394. \nhttps:\/\/doi.org\/10.1016\/j.neulet.2017.06.034","journal-title":"Neurosci Lett"},{"key":"15_CR29","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1126\/science.7973629","volume":"266","author":"P Dawson","year":"1994","unstructured":"Dawson P, Muir T, Clark-Lewis I, Kent S (1994) Synthesis of proteins by native chemical ligation. Science 266:776\u2013779","journal-title":"Science"},{"key":"15_CR30","doi-asserted-by":"publisher","first-page":"6705","DOI":"10.1073\/pnas.95.12.6705","volume":"95","author":"TW Muir","year":"1998","unstructured":"Muir TW, Sondhi D, Cole PA (1998) Expressed protein ligation: a general method for protein engineering. Proc Natl Acad Sci USA 95:6705\u20136710","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR31","doi-asserted-by":"publisher","first-page":"5032","DOI":"10.1021\/acs.orglett.8b02182","volume":"20","author":"CA Leon De","year":"2018","unstructured":"De Leon CA, Lang G, Saavedra MI, Pratt MR (2018) Simple and efficient preparation of O- and S-GlcNAcylated amino acids through InBr3-catalyzed synthesis of \u03b2-N-acetylglycosides from commercially available reagents. Org Lett 20:5032\u20135035. \nhttps:\/\/doi.org\/10.1021\/acs.orglett.8b02182","journal-title":"Org Lett"}],"container-title":["Methods in Molecular Biology","Expressed Protein Ligation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-0434-2_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T15:43:50Z","timestamp":1583509430000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-0716-0434-2_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9781071604335","9781071604342"],"references-count":31,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-0434-2_15","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"7 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}